Over-the-counter medications: meeting consumer needs in the digital age
Elsevier eBooks · 175-186
Research outputs
مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.
Elsevier eBooks · 175-186
Elsevier eBooks · 219-240
Elsevier eBooks · 249-271
Elsevier eBooks · 191-223
Elsevier eBooks · 171-196
Elsevier eBooks · 581-614
Advances in computational intelligence and robotics book series · 275-302
Medication adherence remains a significant challenge within healthcare systems globally, especially among groups with chronic illnesses like diabetes, hypertension, and asthma. Despite universally accessible, low-cost Artificial Intelligence (AI) technologies to adherence, an information crevice exists on the utilization of this innovation and its effect on medicine self-efficacy and pharmaceutical adherence in therapeutically underserved populations with an assortment of persistent sicknesses. AI-enabled smartphone applications have surfaced as an encouraging remedy, presenting innovative methods to monitor patient behaviors, verify medication consumption, and deliver personalized reminders. By utilizing real-time monitoring, tailored communication, and behavioral nudges, AI can tackle the various barriers to medication adherence through creative solutions, including forgetfulness, lack of motivation, and insufficient health literacy, while fostering improved health outcomes, particularly among individuals with chronic conditions.
Advances in computational intelligence and robotics book series · 169-188
This chapter discusses the roles of digital biomarkers and artificial intelligence in enhancing precision therapeutics, which is the adaptation of treatments to a person's biomarker patterns for improving an individual's health. Digital biomarkers are collected from wearable technology and other digital devices that record variations in physiological and behavioral indexes thus improving disease diagnosis and treatment. This AI augments these biomarkers' prognostic accuracy and unearths patterns within large datasets within clinical settings; a major change to individualized care. This chapter in the book describes passive and active data acquisition in actual clinical scenarios and offers a conceptual foundation for employing digital biomarkers and artificial intelligence in trials. It also examines diagnostic image analysis and more specifically, the use of MRI to monitor Parkinson's disease, and EEG in managing mental health.
Studies in big data · 167-181
International review of cytology · مجلد 387 · 143-193
Elsevier eBooks · 251-260
Elsevier eBooks · 255-267
IntechOpen eBooks
The postnatal phase is the first six weeks after delivery and is a critical time for mothers, newborns, and other caregivers as a highly neglected phase of a transition period. Almost all maternal and neonatal deaths occur in low- and middle-income countries, where fewer services are provided for mothers after the delivery period, which constitutes a tremendous challenge facing mothers in these countries. Barriers were markedly observed in low-and middle-income countries as a result of financial constraints, distance from the health center, poor programming for postnatal care, negative childbirth experiences, and cultural constraints. Moreover, the unproper advocacy of contraceptive use during the postpartum period impacts prolonged interpregnancy intervals and indirectly increases postpartum complications mainly in low- and middle-income countries. The importance of the quality of postnatal care was frequently addressed to answer the required interventions that should be implemented at the level of healthcare facilities, household, and community levels as part of the process of reducing the impact of postnatal complications, disabilities, and maternal mortality.
BENTHAM SCIENCE PUBLISHERS eBooks · 1-95
Normally, to replace damaged cells or for the purpose of growth, healthy cells can divide according to the proliferation potency, in a systematic and controlled manner. When this mechanism is interfered with in such a way that the cell multiplies beyond the control system, a neoplasm may originate. The name (neoplasm) comes from the ancient Greek words neo, which means “new,” and plasma, which means “creation, formation.”. Even after the underlying trigger is removed, a neoplasm's growth is disorganized with that of the healthy surrounding tissue, and it continues to grow abnormally. When this abnormal neoplastic growth creates a mass, it is referred to as a ” tumor”. There are four primary types of neoplasms (tumor): benign (non cancerous), in situ, malignant (cancerous), and neoplasms of unclear or unidentified behaviour, which follow the pattern of cell development. Oncology is concerned with malignant neoplasms, which are commonly known as malignancies or cancers. In Oncology, many cancer classifications emerged, however, the most notable of which is based on the nomenclature by the type of tissue from which it arises, or by the primary site in the body where it originally appeared. Herein, this chapter will go over the definition of cancer, classifications as well as the key differences between the types of cancers. This chapter will also cover the pathophysiology and epidemiology of the many types of cancers.
Book Publisher International (a part of SCIENCEDOMAIN International) · 193-197
Background: Public protection is greatly enhanced by the knowledge of health care practitioners. Advocates of simulation-based curriculum assert that this modality plays an especially significant role. Auscultation with stethoscope is an indispensable tool for optimal management of cardiopulmonary patients. However, the acquisition of sufficient training in cardiopulmonary auscultation is not straightforward because of the technical and ethical problems. Aims: The aim of this study is to validate a homegrown stethoscope simulator for cardiopulmonary auscultation developed by the author and claimed to be of a low-cost and high-fidelity. Materials and Methods: The hardware was built from a normal clinical stethoscope and a bluetooth headset, and the software is a single PowerPoint presentation slide with links to cardiopulmonary sounds’ audio tracts. The stethoscope simulator was verified by the inventor, and a panel of experts was asked to evaluate its value as a training tool, relevance to practice, physical attributes, realism of experience, ability to perform tasks, realism of material” and realism of auscultation sounds. The validity of this homegrown stethoscope simulator was assessed by a panel of experts. The members had a session on the simulator and how it works, allowed to physically examine the stethoscope simulator, instructed on how to use it, and then auscultated all its cardiopulmonary sounds. A survey was provided to each member of the panel, and they were asked to rate their responses using a 5-point Likert scale as follows: strongly disagree (1), disagree (2), neutral (3), agree (4), and strongly agree (5). Results: Experts in cardiology, respiratory medicine and respiratory care agreed upon the characteristics and attributes of this stethoscope simulator and the observed average of the “global assessment” of the stethoscope simulator was acceptable. The cost of fabrication of one simulator of this type was approximately 100 USD. Conclusion: Primary evidence shows that this homegrown stethoscope simulator is a valuable instrument that can be built into bedside training and clinical experience labs to help undergraduate students understand and teach cardiopulmonary auscultation.